Provenance Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Provenance Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.58K	Buy	+3	New	+$1.68K	﹤0.01%	468

Other funds holding IDXX

MBI

Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $10.3B AUM 3.26% 1-Year Est. Return

Provenance Wealth Advisors's IDXX Position: Q2 2026 in Review

Provenance Wealth Advisors opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 3 shares worth $1.58K. The stake represents ﹤0.01% of the portfolio and ranks #468 among its holdings.

500 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Provenance Wealth Advisors held 3 shares of Idexx Laboratories worth $1.58K as of Q2 2026.
Idexx Laboratories was a new Provenance Wealth Advisors position in Q2 2026.
Idexx Laboratories made up ﹤0.01% of Provenance Wealth Advisors's portfolio in Q2 2026, its #468 holding.
500 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Provenance Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.